The Effect of Hydrocortisone on Neurodevelopmental Outcome in Premature Infants Less than 29 Weeks’ Gestation

Abstract

The use of postnatal dexamethasone in premature newborns can be associated with a deleterious neurodevelopmental outcome. The effect of hydrocortisone on developmental outcome in these patients is less clear. We therefore sought to examine the effect of hydrocortisone on early developmental outcome in premature newborns. We retrospectively examined the effect of hydrocortisone on developmental outcome during the first 2 years of life in premature infants <29 weeks’ gestation at birth. Even though hydrocortisone was used in infants with a greater risk for poor outcome, its use, unless prolonged >7 days, was generally not associated with a worse developmental outcome or higher rate of referral for early intervention. A short course of hydrocortisone in sick premature newborns does not appear to have a deleterious effect on developmental outcome.

Keywords

early intervention hydrocortisone NICU developmental outcome

Get full access to this article

View all access options for this article.

References

Mammel MC , Green TP , Johnson DE , Thompson TR Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet. 1983;1(8338):1356-1358.

Yeh TF , Lin YJ , Lin HC , et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350(13):1304-1313.

Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in premature infants. Pediatrics. 2002;109(2):330-338.

American Academy of Pediatrics. AAP publications retired or reaffirmed, May 2004. Pediatrics . 2006;117(5):1846-1847.

Shinwell ES , Karplus M. , Becker D. , et al. Neonatologists are using much less dexamethasone. Arch Dis Child Fetal Neonatal Ed. 2003;88 (5):F432-F433.

Rademaker KJ , devries LS , Viterwaal Cspm , et al. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up. Arch Dis Child Fetal Neonatal Ed. 2008;93(1):F58-F63.

Seri I. Hydrocortisone and vasopressor-resistant shock in preterm neonates . Pediatrics. 2006;117(2):516-518.

Bayley N. In: Bayley Scales of Infant Development. 2nd ed., San Antonio, TX: The Psychological Corporation; 1993.

Knobloch, H. , Stevens, F. , Malone AF Manual of Developmental Diagnosis. New York, NY : Harper and Row; 1980.

10.

Piper MC , Darrah J. Motor Assessment of the Developing Infant. Philadelphia , PA: Saunders; 1994.

11.

Vohr B. , Msall ME Follow-up of high-risk infants. In: Vergara ER , BIgsby, R , eds. Developmental and Therapeutic Interventions in the NICU. Baltimore, MD: Brookes; 2004:267-293.

12.

Nebraska Department of Education Title 92.

13.

Needelman H. , Evans M. , Roberts H. , Sweney M. , Bodensteiner JB Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants. J Child Neurology. 2008;23(4): 421-424.

14.

Sattler JM Assessment of Children: Cognitive Applications. San Diego, CA: Sattler; 2001:169-170, 547-548.

15.

Parikh NA , Lasky RE , Kennedy KA , et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics. 2007;119(2):265-272.

16.

Watterberg KL , Shaffer ML , Mishefske MJ , et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics. 2007;120(1):40-48.

17.

DeKloet RE , Vreugdehn LE , Oitel MS , Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998; 19(3):269-301.

18.

Almeida OFX , Conde GL , Crochemore C. , et al. Subtle shifts in the ratio between pro and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 2000 ; 14(5):779-790.

19.

Ladygensky GA , Rademaker K. , Zimme S. , et al. Structural and functional brain development after hydrocortisone treatment for chronic lung disease. Pediatrics. 2005;116(1):1-7.

20.

Rademaker KJ , Viterseal Cspm , Gruenendel F. , et al. Neonatal hydrocortisone treatment: Neurodevelopmental outcome and MRI at school age in preterm born children . J Pediatr. 2007; 150(4):351-357.

21.

Lattimore KA , Vazquez DM , Barks JD , Bhatt-Mehta V. Developmental outcome of very low birth weight infants treated with hydrocortisone for refractory hypotension. J Neonatal Perinatal Med. 2008 ;1(4):225-232.